human growth hormone

Crinetics pads case for oral hormone disorder drug

Crinetics' oral med regulated levels of a hormone associated with acromegaly in a phase 3 test, setting up a regulatory submission in the second half.

Annalee Armstrong Mar 19, 2024 9:30am

Crinetics growth disorder drug sees ph. 2 carcinoid syndrome win

Mar 13, 2024 9:16am

butterfly monarchs fly bugs wings flutter

I-Mab sheds China footprint to transform into US-based biotech

Feb 7, 2024 8:50am

target reach ladder climb meet win beat competition

Lumos stock rockets on oral growth hormone phase 2 results

Nov 8, 2023 9:40am

Genexine's weekly growth hormone equal to Novo shot in phase 3

Aug 31, 2023 6:00am

Ascendis scores in phase 3 trial, a boost to endocrine portfolio

Mar 14, 2022 11:15am